Pharmafile Logo
Pharmafocus logo
Advanced Search

lung cancer

Showing 8 posts of 203 posts found.

Daiichi’s lung cancer drug progresses to phase III

August 5, 2010
Research and Development Daiichi, arq 197, arqule, lung cancer, phase III

Daiichi Sankyo and biotech firm Arqule are to move their lung cancer treatment ARQ 197 into phase III trials. The …

News
Tarceva

NICE rejects Tarceva maintenance treatment

June 17, 2010
Sales and Marketing NICE, NSCLC, Roche, Tarceva, lung cancer

Roche’s Tarceva should not be used in lung cancer patients who have already been treated and whose disease remains stable, …

News

Antisoma cancer drug fails in phase III

March 29, 2010
Research and Development Antisoma, NSCLC, lung cancer

UK biotech Antisoma has suffered a disappointing late-stage failure with a potential lung cancer treatment it was developing with Novartis. …

News

Tarceva gets nod for maintenance treatment

March 22, 2010
Sales and Marketing Tarceva, lung cancer

Tarceva looks set to gain approval in Europe to treat patients with non-small cell lung cancer whose disease remains stable …

News

Novartis buys into Transgene’s lung cancer candidate

March 11, 2010
Research and Development Novartis, Transgene, immunotherapy, lung cancer

French biotech company Transgene has signed a deal with Novartis for the future development and marketing of its potential lung …

News
lung cancer

New approaches in lung cancer

January 1, 2010
Sales and Marketing lung cancer

Lung cancer is the most common cancer in the world, with 1.3 million new cases diagnosed every year. The vast …

Feature

Avastin approved as first-line treatment for lung cancer

August 24, 2007
Sales and Marketing avastin, lung cancer

Roche's cancer drug Avastin has gained European approval as a first-line treatment for lung cancer on the back of data …

News

NICE judges Tarceva too expensive for NHS

March 9, 2007
Sales and Marketing Tarceva, lung cancer

Roche's cancer drug Tarceva has been rejected by NICE for use against the most common form of lung cancer.The watchdog …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025